Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04326179 · ClinicalTrials.gov registry record
Targeting Infant Development With Early Screening
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 7,720
- Enrollment target
NCT04326179: Completed study, sponsored by Duke University.
NCT04326179 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 7,720 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04326179 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 7,720 participants
- Enrollment target
Study Summary
The purpose of this study is to assess feasibility and acceptability of parent-completed screeners of child social/emotional development, social determinants of health, and adverse childhood experiences in the setting of a pediatrics primary care clinic.
Primary Outcome
We will use data extracts from the electronic health system to examine rates of meeting positive/negative thresholds on screening tools used as part of clinical care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,720 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2021-08-06 |
What the finished NCT04326179 record still lists
NCT04326179 is an observational study that tracks outcomes without assigning an intervention. Its 7,720 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04326179 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04326179 about?
NCT04326179 is a clinical study titled "Targeting Infant Development With Early Screening". The purpose of this study is to assess feasibility and acceptability of parent-completed screeners of child social/emotional development, social determinants of health, and adverse childhood experiences in the setting of a pediatrics primary care clinic.
What is the current status of trial NCT04326179?
This trial is currently completed. The enrollment target is 7,720 participants. The study started on 2019-11-04. Estimated completion is 2021-08-06.
Who is sponsoring clinical trial NCT04326179?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06560398 · 7,649 participants · NA
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
- NCT03848312 · 7,600 participants · Phase 3
Preventing Alzheimer's With Cognitive Training
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI